Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?

Immunobiology

Volumn 219, Issue 4, 2014, Pages 275-284

  Basso, B ^a,b   Marini, V ^c  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b National Co ordination of Vector Control   (Argentina)

^c UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

Author keywords

Innate immune response; Macrophages; Peritoneal fluid; Trypanosoma cruzi; Trypanosoma rangeli

Indexed keywords

EPITOPE; PROTOZOAL VACCINE; TRYPANOSOMA RANGELI VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL ADHESION; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL RATE; TRYPANOSOMA CRUZI; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; HUMAN; IMMUNOLOGY; PARASITOLOGY; TRYPANOSOMA RANGELI; VACCINATION;

ANIMALS; CELLS, CULTURED; CHAGAS DISEASE; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PHAGOCYTOSIS; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI; VACCINATION;

EID: 84895435914     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.10.012     Document Type: Article

References (52)

1. Afchain D., Le Ray D., Fruit J., Capron A. Antigenic make-up of Trypanosome cruzi culture forms: identification of a specific component. J. Parasitol. 1979, 65:507-514.
2. Añez N., Velandia J., Rodriguz A.M. Estudios sobre Trypanosoma rangeli, Tejera, 1920. VIII. Respuesta a las reinfecciones en dos mamíferos. Mem. Inst. Oswaldo Cruz, Rio de Janeiro 1985, 80:149-153.
3. Basso B., Moretti E., Vottero-Cima E. Comportamiento antigénico del Trypanosoma cruzi y del Trypanosoma rangeli frente a sueros de pacientes con Enfermedad de Chagas. Medicina (B. Aires) 1984, 44:475-479.
4. Basso B., Moretti E., Vottero-Cima E. Antigenic relationships between Trypanosoma cruzi and Trypanosoma rangeli. Rev. Iberoam. Parasitol. 1987, 47:15-21.
5. Basso B., Moretti E., Fontenla S., Vottero-Cima E. Trypanosoma (Schizotrypanum) cruzi and Trypanosoma (Herpetosoma) rangeli II. Overlaping of antigenic spectrum. Rev. Latinoam. Microbiol. 1989, 31:141-146.
6. Basso B., Moretti E., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Hyg. 1991, 44(4):413-419.
7. Basso B., Cervetta L., Moretti E., Carlier Y., Truyens C. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF-α, sTNFR and NO in Trypanosoma rangeli-vaccinated mice. Vaccine 2004, 22:1868-1872.
8. Basso B., Moretti E., Fretes R. Vaccination with fixed epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2008, 103:370-374.
9. Bonney K.M., Taylor J.M., Daniels M.D., Epting C.L., Engman D.M. Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS ONE 2011, 21(1):e14571.
10. Cazorla S.I., Frank F.M., Malchiodi E.L. Vaccination approaches against Trypanosoma cruzi infection. Expert Rev. Vaccine 2009, 8:921-935.
11. Chiurillo M., Crisante G., Rojas A., Peralta A., Dias M., Guevara P., Añez N., Ramírez J. Detection of Trypanosoma cruzi and Trypanosoma rangeli infection by duplex PCR assay based on telomeric sequences. Clin. Diagn. Immunol. 2003, 10(5):775-779.
12. Coura J.R. Chagas disease: what is known and what is need - a background article. Mem. Inst. Oswaldo Cruz 2007, 102:113-122.
13. De Souza W., Ulisses de Carvalho T., Santos Barrias E. Review on Trypanosoma cruzi: host cell interaction. Int. J. Cell Biol. 2010, (ID 295394).
14. Fabrino D.L., Leon L.L., Genestra M., Parreira G.G., Melo R.C. Rat models to investigate host macrophage defense against Trypanosoma cruzi. J. Innate Immunol. 2011, 3(1):71-82.
15. Flechas I.D., Cuellar A., Cucunubá Z.M., Rosas F., Velasco V., Steindel M., Thomas M.del C., López M.C., González J.M., Puerta C.J. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect. Dis. 2009, 9:186. 10.1186/1471-2334-9-186.
16. Fontanella G.H., De Vusser K., Laroy W., Daurelio L., Nocito A., Revelli S., et al. Immunization with an engineered mutant trans-silidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Vaccine 2008, 226:2322-2334.
17. Franco-Paredes C., Bottazzi M., Hotez P. The unfinished public health agenda of Chagas disease in the era of globalization. PLoS 2009, 3(7):e470.
18. Garcia E., Castro D., Figueiredo M., Genta F., Azambuja P. Trypanosoma rangeli: a new perspective for studying the modulation of immune reactions of Rhodnius prolixus. Parasites Vectors 2009, 2:33.
19. Giordanengo L., Guiñazú N., Stempin C., Fretes R., Cerbán F., Gea S. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002, 32(4):1003-1011.
20. Gironès N., Cuervo H., Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr. Top. Microbiol. Immunol. 2005, 296:89-123.
21. Grisard E., Steindel M., Guamieri A., Eger-Mangrich I., Campbell D., Romahna A. Characterization of Trypanosoma rangeli strains isolated in Central and South America: an overview. Mem. Inst. Oswaldo Cruz 1999, 94:203-209.
22. Grogl M., Kuhn R. Identification of antigens of cultures of Trypanosoma cruzi and Trypanosoma rangeli recognized by sera from patients with chronic Chagas disease. J. Parasitol. 1984, 70:822-824.
23. Guiñazú N., Pellegrini A., Carrera-Silva E.A., Aoki M.P., Cabanillas A.M., Gìronés N., et al. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression. Int. J. Parasitol. 2007, 37(11):1243-1254.
24. Gutierrez F., Mineo T., Pavanelli W., Guedes P., Silva J. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2009, 104:236-245.
25. Hernández-Osorio L., Márquez-Dueñas C., Florencio-Martínez L., Ballesteros-Rodea G., Martínez-Calvillo S., Manning-Cela R. Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms. J. Biomed. Biotechnol. 2010, (ID 283842). 10.1155/2010/283842.
26. Introini M., Basso B., Moretti E. Enfermedad de Chagas experimental: I estudio de diferentes condiciones de inmunización sobre el curso de la infección. Bol. Chil. Parasitol. 1998, 53:45-51.
27. Lemesre J.-L., Holzmuller P., Cavaleyra M., Bras G., Hottin G., Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 2005, 23:2825-2840.
28. Marinho C., Bastos K., Sardinha L., Grisotto M., Lima M., Alvarez J. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. J. Parasitol. 2004, 90:516-523.
29. Marini V., Moretti E., Bermejo D., Basso B. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection. Mem. Inst. Oswaldo Cruz 2011, 106(1):32-37.
30. McCabe R.E., Mullins B.T. Failure of Trypanosoma cruzi to trigger the respiratory burst of activated macrophages. Mechanism for immune evasion and importance of oxygen-independent killing. J. Immunol. 1990, 144(6):2384-2388.
31. Michailowsky V., Silva N., Rocha C., Vieira L., Lannes-Vieira J., Gazzinelli R. Pivotal role of interleukin-12 and interferon-γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 159(5):1723-1733.
32. Minning T., Bua J.G., Garcia G., McGraw R., Tarleton R. Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi. Mol. Biochem. Parasitol. 2003, 131:55-64.
33. Morán-Utrera Y., López-Monteon A., Rosales-Encina J., Méndez-Bolaina E., Ramos-Ligonio Trypanosoma cruzi SSP4 amastigote protein induces expression of immunoregulatory and immunosuppressive molecules in peripheral blood mononuclear cells. J. Trop. Med. 2012, (ID: 829139). 10.1155/2012/829139.829139.
34. Navarro M., De Lima A., Askue J., Contreras V. Morphological comparison of axenic amastigogenesis of trypomastigotes and metacyclic forms of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 2003, 98(1):83-91.
35. Noireau F. Wild Triatoma infestans, a potential threat that needs to be monitored. Mem. Inst. Oswaldo Cruz 2009, 104:60-64.
36. Novais F., Santiago R., Bafica A., Khouri R., Afonso L., Borges V., Brodskyn V., Barral-Netto M., Barral A., Oliveira C. Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J. Immunol. 2009, 183:8088-8098.
37. Palau M.T., Mejia A.J., Vergara U., Zuniga C.A. Action of Trypanosoma rangeli in infections with virulent. Trypanosoma cruzi populations. Mem. Inst. Oswaldo Cruz 2003, 98:543-548.
38. Peiser L., Mukhopadhyay S., Gordon Scavenger receptors in innate immunity. Curr. Opin. Immunol. 2002, 14:123-128.
39. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., Radi R. l-Arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 2004, 20(8):363-369.
40. Pinto Dias J., Amato Neto V. Prevention concerning the different alternative route for transmission of Trypanosoma cruzi in Brazil. Rev. Soc. Bras. Med. Trop. 2011, 44(2):62-68.
41. Planelles L., Thomas M., Marañón C., Morell M., López M. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin. Exp. Immunol. 2003, 131:41-47.
42. Roggero E., Perez A., Tamae-Kazazu M., Piazzoni I., Nepomnaschy I., Wietzerbin, et al. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin. Exp. Immunol. 2002, 128:421-428.
43. Saldaña A., Sousa O.E. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. J. Parasitol. 1996, 82:363-366.
44. Silva M. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol. 2010, 87:805-813.
45. Silva J., Machado F., Martins G. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 2003, 8:S314-S325.
46. Stafford J., Neumann N., Belosevic M. Macrophage-mediated innate host defense against protozoa parasites. Crit. Rev. Microbiol. 2002, 28:187-248.
47. Stempin C., Giordanengo L., Gea S., Cerbán F. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukoc. Biol. 2002, 72:727-733.
48. Stempin C., Dulgerian L., Garrido V., Cerban F. Arginase in parasitic infections: macrophage activation, immunosuppression and intracellular signals. J. Biomed. Biotechnol. 2010, 10. (article ID 683485).
49. Taniwaki N.N., Gonçalves V.M., Romero J.K., da Silva C.V., da Silva S., Mortara R.A. Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression. Parasitol. Res. 2011, 109(2):431-440.
50. Teixeira A., Nitz N., Guimaro M., Gomes C., Santos, Busch C. Chagas disease. Postgrad. Med. J. 2006, 82:788-798.
51. Yoshida N. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol. Int. 2008, 57(2):105-109.
52. Zuñiga C., Palau T., Penin P., Gamallo C., de Diego J.A. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Trop. Med. Int. Health 1997, 2(5):482-487.